CMS Offers Additional Guidance on 2011 Coverage for Generic Drugs in the Coverage Gap
This memorandum addresses questions CMS has received concerning 2011 bid submissions and the new provision regarding coverage for generic drugs in the coverage gap recently enacted under the Patient Protection and Affordable Care Act (H.R. 3590) (PPACA), as amended by the Health Care and Education Reconciliation Act of 2010 (H.R. 4872) (HCERA). We previously provided background for this new provision as well as bid submission instructions in the 2011 Part D Plan Benefit Package (PBP) Submission and Review Instructions memorandum posted on April 16, 2010.
View the complete memorandum